Disseminated Nocardia nova in a child with relapsed acute lymphoblastic leukemia: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Disseminated Nocardia nova in a child with relapsed acute lymphoblastic leukemia: a case report ; volume:24 ; number:1 ; day:1 ; month:2 ; year:2024 ; pages:1-6 ; date:12.2024
BMC infectious diseases ; 24, Heft 1 (1.2.2024), 1-6, 12.2024
- Creator
-
Arahirwa, Victor
Thahir, Sahal
Hernandez, Lauren
Willis, Zachary Inskeep
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-023-08895-5
- URN
-
urn:nbn:de:101:1-2024041215321279800506
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Arahirwa, Victor
- Thahir, Sahal
- Hernandez, Lauren
- Willis, Zachary Inskeep
- SpringerLink (Online service)
Other Objects (12)
Relapsed Acute Lymphoblastic Leukemia
Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia
Promoter methylation signatures in relapsed pediatric T-cell acute lymphoblastic leukemia
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia
Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
Genetic alterations in childhood relapsed high hyperdiploid B-cell acute lymphoblastic leukemia
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia
Promoter methylation signatures in relapsed pediatric T-cell acute lymphoblastic leukemia
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia
Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
Genetic alterations in childhood relapsed high hyperdiploid B-cell acute lymphoblastic leukemia
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Acute lymphoblastic leukemia
Relapsed Acute Lymphoblastic Leukemia
Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia
Promoter methylation signatures in relapsed pediatric T-cell acute lymphoblastic leukemia
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia
Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
Genetic alterations in childhood relapsed high hyperdiploid B-cell acute lymphoblastic leukemia
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia